A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
Nicola Martinelli, Martina Montagnana, Francesca Pizzolo, Simonetta Friso, Gian Luca Salvagno, Gian Luca Forni, Barbara Gianesin, Matteo Morandi, Claudio Lunardi, Giuseppe Lippi, Enrico Polati, Oliviero Olivieri, Lucia De Franceschi
Topics & Concepts
ADAMTS13Thrombotic microangiopathyCoronavirus disease 2019 (COVID-19)Microangiopathy2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineInternal medicineEndocrinologyDiabetes mellitusThrombotic thrombocytopenic purpuraOutbreakDiseasePlateletInfectious disease (medical specialty)Complement system in diseasesMechanical Circulatory Support DevicesSARS-CoV-2 and COVID-19 Research